Marvel Studios' Phase 5 came to an end with Ironheart last week, and we're reflecting on this tumultuous chapter in the ...

After a season of regulatory upheaval, obesity and rare genetic diseases will likely remain major themes for biopharma in ...

FTAI Infrastructure’s first quarter saw year-on-year revenue growth, though results came in below Wall Street’s sales ...

New and Unprecedented Survival, Respiratory, and Biomarker Data Prove that NurOwn Helps People with ALS Live Longer and Live ...

Milestone Pharmaceuticals Inc. is a strong buy under $2 with FDA approval for Cardamyst expected in 2026, offering unique ...

Boehringer Ingelheim today announces the start of the THULITE Phase II clinical study (NCT06962839). It will investigate the efficacy, safety and tolerability of BI 1815368 as a potential oral ...

A proposed layout for the initial phase of Rochester’s planned sports and recreation complex has been finalized.

A former top bureaucrat who worked closely with Treasurer Jim Chalmers wants boomers to be hit with a new tax on their ...

The countdown to the next market breakout has already begun, and July is shaping up to be a defining moment for crypto ...

Wave Life Sciences could offer significant upside if obesity candidate WVE-007 delivers strong human data. Check out the ...

DU UG Admission 2025: The Delhi University has announced the schedule for Phase 2 of the Common Seat Allocation System (CSAS) ...

The Indian Institutes of Technology (IITs) are reshaping their academic offerings by phasing out traditional five-year dual ...